Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Entasis Therapeutics Holdings Inc. | VP, Principal Fin & Acct Off | Common Stock | 0 | $2.20 | Jul 11, 2022 | Direct | |
Entasis Therapeutics Holdings Inc. | VP, Principal Fin & Acct Off | Stock Option (right to buy) | 0 | Jul 11, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ETTX | Entasis Therapeutics Holdings Inc. | Jul 11, 2022 | 2 | $0 | 4 | Jul 11, 2022 | VP, Principal Fin & Acct Off |
ETTX | Entasis Therapeutics Holdings Inc. | Feb 24, 2022 | 1 | $0 | 4 | Feb 25, 2022 | VP, Principal Fin & Acct Off |
ETTX | Entasis Therapeutics Holdings Inc. | Feb 24, 2022 | 0 | $0 | 3 | Feb 25, 2022 | VP, Principal Fin & Acct Off |